The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target
Authors
Keywords
Lung and intrathoracic tumors, Cancer treatment, Small interfering RNAs, Small cell lung cancer, Non-small cell lung cancer, Protein expression, Transfection, DAPI staining
Journal
PLoS One
Volume 8, Issue 7, Pages e67668
Publisher
Public Library of Science (PLoS)
Online
2013-07-03
DOI
10.1371/journal.pone.0067668
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EGFR-mutated lung cancer: a paradigm of molecular oncology
- (2015) Oncotarget
- Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer
- (2013) Hongyun Zhao et al. PLoS One
- Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers
- (2012) R. Hasina et al. CANCER RESEARCH
- MET Increases the Sensitivity of Gefitinib-Resistant Cells to SN-38, an Active Metabolite of Irinotecan, by Up-Regulating the Topoisomerase I Activity
- (2012) Asao Sakai et al. Journal of Thoracic Oncology
- ALK-Mutated Non-Small-Cell Lung Cancer: A New Strategy for Cancer Treatment
- (2012) Luis Cabezón-Gutiérrez et al. LUNG
- Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma
- (2012) Masashi Ishikawa et al. LUNG CANCER
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- In cancer drug resistance, germline matters too
- (2012) Emily H Cheng et al. NATURE MEDICINE
- EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex
- (2012) Guo Li et al. Nature Communications
- Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series
- (2011) Bernard Barlaam et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- EphB3 Is Overexpressed in Non-Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration
- (2011) X.-D. Ji et al. CANCER RESEARCH
- Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis
- (2011) Nirmitha I. Herath et al. EUROPEAN JOURNAL OF CANCER
- Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib
- (2011) Hua Cheng et al. Journal of Hematology & Oncology
- The role of the c-Met pathway in lung cancer and the potential for targeted therapy
- (2011) Martin Sattler et al. Therapeutic Advances in Medical Oncology
- Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors
- (2010) Catherine Bardelle et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- EphA2Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation
- (2010) Leonardo Faoro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer
- (2010) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Converging Evidence for Efficacy from Parallel EphB4-Targeted Approaches in Ovarian Carcinoma
- (2010) Whitney A. Spannuth et al. MOLECULAR CANCER THERAPEUTICS
- Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy
- (2010) Yan Shi et al. TUMOR BIOLOGY
- Preferential Induction of EphB4 over EphB2 and Its Implication in Colorectal Cancer Progression
- (2009) S. R. Kumar et al. CANCER RESEARCH
- Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers
- (2009) Syed Mahfuzul Alam et al. GYNECOLOGIC ONCOLOGY
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung
- (2009) Yoshihiro Minamiya et al. LUNG CANCER
- The Significance of EphB4 and EphrinB2 Expression and Survival in Head and Neck Squamous Cell Carcinoma
- (2008) Eric J. Yavrouian et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines
- (2008) Catherine Bardelle et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibitors of the tyrosine kinase EphB4. Part 2: Structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines
- (2008) Catherine Bardelle et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade
- (2008) J. S. Scehnet et al. BLOOD
- Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
- (2008) S M Alam et al. BRITISH JOURNAL OF CANCER
- Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
- (2008) Andreas Hermes et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started